<DOC>
	<DOCNO>NCT00004454</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate safety feasibility treat mucopolysaccharidosis II ( mild Hunter syndrome ) lymphocyte gene therapy . II . Determine level iduronate-2-sulfatase enzyme patient attain infuse increase dos lymphocytes transduced retroviral vector design insertion expression iduronate-2-sulfatase gene ( L2SN ) . III . Determine duration survival transduce cell patient . IV . Determine whether monthly infusion L2SN-transduced lymphocytes accomplishes metabolic correction ( measure glycosaminoglycan excretion ) , decrease liver spleen volume , therapeutic effect upon cardiac pulmonary dysfunction , effect treatment .</brief_summary>
	<brief_title>Phase I/II Study Retroviral-Mediated Transfer Iduronate-2-Sulfatase Gene Into Lymphocytes Patients With Mucopolysaccharidosis II ( Mild Hunter Syndrome )</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Peripheral blood lymphocyte harvest patient apheresis , stimulate initiate growth T-lymphocytes , transduce retrovirus L2SN contain iduronate-2-sulfatase , reinfused patient . Patients receive 12 monthly infusion retroviral-mediated gene transduce lymphocyte first three infusion dose escalation format . Patients monitor least 2 hour completion infusion . Patients follow 1 year treatment , death .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis II</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Mucopolysaccharidosis II ( mild Hunter syndrome ) define follow : Characteristic coarse facial feature , hepatosplenomegaly , radiographic evidence dysostosis multiplex Elevated urinary excretion glycosaminoglycans 3 urine specimen Deficient iduronate2sulfatase enzyme activity measure plasma leukocyte Mutation consistent mild Hunter syndrome must either : A single base substitution cod sequence previously associate severe Hunter syndrome phenotype OR An exonskipping mutation would allow occasional production ( minimal amount ) normal protein Patient Characteristics Cardiovascular : No severe cardiac disease Pulmonary : No severe respiratory disease Other : Must IQ score 80 higher Effective contraception require fertile patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2003</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>mucopolysaccharidosis</keyword>
	<keyword>mucopolysaccharidosis II</keyword>
	<keyword>rare disease</keyword>
</DOC>